In a complaint filed in the U.S. District Court for the Eastern District of Virginia, Three Rivers claimed Zydus’ ribavirin caplets and tablets infringe on its patent, U.S. Patent No. 6,720,000. The patent describes a method for producing ribavirin pellets, which Three Rivers markets and sells under the brand name Ribasphere.